Last session of the day converting the genomes into phylogenetic trees to understand the evolution and transmission of #AMR @fcic.bsky.social
Posts by Ewan Harrison
Day 4 - part 2 AMR of Bacterial Pathogens - Africa course #AMRBactcourse on the sequencing practical with Nanopore led by @effkay88.bsky.social Huge thanks to the team from @nanoporetech.com South Africa @eventswcs.bsky.social @sangerinstitute.bsky.social
The variation and problems encountered demonstrate the importance of QC and QA in AMR testing and that is important to consider when analysing genomics data for AMR. Huge thanks to the team at NICD Charm.
All the data across the different groups is compared. @effkay88.bsky.social @fcic.bsky.social
Day 4 - AMR of Bacterial Pathogens - Africa course #AMRBactcourse. AMR testing results day… Results of disk testing, e-tests, and micro-dilution @eventswcs.bsky.social @sangerinstitute.bsky.social @cam.ac.uk
@eventswcs.bsky.social
@fcic.bsky.social @effkay88.bsky.social @belamalta10.bsky.social
Day 3 of AMR of Bacterial Pathogens - Africa course at NICD Johannesburg. Split day into the lab for AMR disk testing, MICs and broth micro-dilution. On the computers and lectures on online and command line AMR tools, MLST and phylogeny. Busy day! @sangerinstitute.bsky.social @engagewcs.bsky.social
First day covered a lot of the basics including sequencing technology and AMR resistance and evolution
Fantastic second day of Antimicrobial Resistance of Bacterial Pathogens - Africa course at NICD Johannesburg. Packed day - covering the basics of genomics, the command line, QC, genotype-to-phenotype, assembly and alignments. @sangerinstitute.bsky.social @engagewcs.bsky.social @fcic.bsky.social
Lovely work driven by Lizzie Ledger in the group: a new but druggable mechanism by which Staphs produce biofilm using components of human serum. First polysaccharides, then protein, then eDNA, now lipids too!
bsky.app/profile/bior...
We are very happy to see our study finally appear online @nature.com! This has been work of nearly 10 years in collaboration with the National Institute of Genome Medicine 🇲🇽, the National Cancer Institute 🇲🇽, the @sangerinstitute.bsky.social and others ⬇️
www.nature.com/articles/s41...
Incredible time at #AIR2026 covering breadth of respiratory infection, microbiomes and immunology with some really beautiful biology. Thanks to fellow committee members @resp-micro.bsky.social @drclairesmith.bsky.social @ewanharrison.bsky.social , Alex Kayongo and organisers @eventswcs.bsky.social
Another insightful day of science, discussion and making new friends at #AIR2026
Day 2 Highlights: making sense of big data, spatial transcriptomics and in vitro modelling of respiratory infections @eventswcs.bsky.social @sangerinstitute.bsky.social
Our new preprint which reimplements "the NFDS model" (of Corander et al) to forecast populations after vaccination as a compartmental model, and uses new bioinformatic tools to create and process the pangenome data
We look at which surveillance strategies are best to correctly forecast changes
Brilliant news!
Work on respiratory immunology or microbes? Interested in big data, omics or the latest in vitro models?... Treat your lab to a christmas present of AIR 2026 registration!
Feb 11th-13th, registration closing soon:
coursesandconferences.wellcomeconnectingscience.org/event/air-20...
Other work using the same cohort is in progress looking at the role of human genetics led by @roisinboggan.bsky.social and metagenomics of the nasal microbiome in larger numbers of CARRIAGE study participants by @duncan-ng.bsky.social
We also found some interesting differences in the nasal microbiome between men and women, and between the strains of S. aureus that are present at high abundance. This all now needs evaluation in larger numbers and different human populations.
We found that people less likely to carry S. aureus tended to have more of Dolosigranulum pigrum, Staphylococcus epidermidis and Moraxella catarrhalis. These bacteria may crowd out, kill or compete with S. aureus, but that requires further study.
This confirms previous data and hypothesis that ‘ intermittent carriers’ (people who will sometime be positive for S. aureus and sometimes not) aren’t a distinct biological group - rather they have microbiomes just like persistent or non-carriers.
Combining nasal microbiome data and culture data we show when S. aureus is present, it often dominates. We can group the nasal microbiome into two major patterns:
1. S. aureus dominated with overall low microbial diversity
2. S. aureus is rare, and there is a greater diversity of other bacteria.
This is of important because people who are colonised are at higher risk of S. aureus infection - which is why you get swabbed when you are admitted to hospital.
Over the last 70yrs using nasal swabs and culture it has been established that some people are persistently colonised by Staphylococcus aureus, while others never are - and third group are positive from time to time (intermittent carriers). We investigated the nasal microbiome in these groups
So a few highlights of the study.
Also thanks to the huge contribution and co-leadership of the CARRIAGE study by @julianparkhill.bsky.social John Danesh, Joan Geoghegan, Sharon Peacock and others in the wider CARRIAGE study team at @cam.ac.uk @sangerinstitute.bsky.social and thanks to @wellcometrust.bsky.social for funding
Great to share the latest work from our group and collaborators. First CARRIAGE study paper led by @drdaggarwal.bsky.social and the heroic efforts of Katie Bellis and Beth Blane in the lab plus all the team at @cambridge-ceu.bsky.social Huge thanks goes to the 22,000 participants of the study
Really pleased to share the first paper to come out of the lab.
We found that hospital patients were frequently colonised with P. aeruginosa and that the same clone was shared between the gut and the lung.
The phylogenies indicate that the clones moved from lung->gut
www.nature.com/articles/s41...